No trading action warranted. This is a routine scheduling extension with zero material impact on Abbott's financials, operations, or litigation risk profile. Monitor for future substantive rulings on class certification or summary judgment.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 12 $110.91entry
- T+1 · 3mo ago +0.32%α −0.37% · $111.27
- T+5 · 3mo ago +3.17%α +3.62% · $114.43
- T+20 · 2mo ago −6.81%α −4.91% · $103.36
- T+60 · 12d ago +2.43%α +7.54% · $113.60
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
This is a routine procedural stipulation in the multi-district FreeStyle CGM consumer litigation against Abbott Diabetes Care Inc. and Abbott Laboratories. The parties jointly requested, and the court granted, a one-month extension of the deadline to submit a proposed ESI protocol from August 12 to September 14, 2026. This is the third such extension and has no bearing on the merits, liability, or financial exposure of the case.
Court Ruling Details
Key Facts
- Parties jointly stipulated to extend the ESI protocol deadline to September 14, 2026.
- This is the third stipulated extension in the case (ECF Nos. 39, 57, 68).
- The order does not alter any other case deadlines or substantive rulings.
- The underlying litigation is a consumer class action over FreeStyle CGM products.
Financial Impact
No financial impact, purely procedural scheduling order with no damages, liability determination, or injunction.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-1d630f42bf-ABT |
Track record
38 reports on ABT
7 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +17.16% at T+20 after the Jul 1, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $109.93 Now $107.45 −2.26% settles Dec 7
- Oct 27, 202620d ago ANALYST-DOWNGRADE Neutral 2/10 Entry $103.10 Now $107.45 +4.22% settles Nov 24
- Oct 27, 202621d ago Court Ruling Neutral 1/10 Entry $102.64 Now $107.45 +4.69% settles Nov 25
- Oct 21, 202626d ago Institutional Cluster Mixed 4/10 Entry $102.51 Now $107.45 +4.82% settles Nov 19
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 21, 202626d ago 8-K Bearish 6/10 No price data
- Oct 21, 202626d ago Press Release Neutral 4/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 20, 202628d ago Court Ruling Neutral 1/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 16, 20264w ago Court Ruling Neutral 2/10 Entry $104.06 to $107.45 Now $107.45 +3.26% ▲ +3.26% +6.72% vs SPY
- Oct 15, 20264w ago Court Ruling Bullish 5/10 Entry $104.89 to $108.52 Now $107.45 +2.44% ▲ +3.46% +4.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers